Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China - Xu, Xin; Sun, Jian; Nie, Sheng; Li, Huiyuan; Kong, Yaozhong; Liang, Min; Hou, Jinlin; Huang, Xianzhong; Li, Dongfeng; Ma, Tean; Peng, Jiaqing; Gao, Shikui; et al. (Nature medicine, 2020)
Keywords: 692/699/255; 692/700/478; Antibodies; Antibodies, Viral - blood; Antibodies, Viral - immunology; Betacoronavirus - pathogenicity; Biomedical and Life Sciences; Biomedicine; Brief Communication; Cancer Research; China - epidemiology; Confidence intervals; Coronavirus Infections - blood; Coronavirus Infections - epidemiology; Coronavirus Infections - virology; Coronaviruses; COVID-19; Diagnosis; Female; Geographical locations; Health aspects; Health Personnel; Hemodialysis; Humans; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin G - immunology; Immunoglobulin M; Immunoglobulin M - blood; Immunoglobulin M - immunology; Immunoglobulins; Infections; Infectious Diseases; Male; Measurement; Medical personnel; Metabolic Diseases; Methods; Middle Aged; Molecular Medicine; Neurosciences; Pandemics; Pneumonia, Viral - blood; Pneumonia, Viral - epidemiology; Pneumonia, Viral - virology; SARS-CoV-2; Sentinel health events; Serodiagnosis; Seroepidemiologic Studies; Serology; Severe acute respiratory syndrome coronavirus 2; Surveillance; Viral diseases; China